The Future of Postoperative Pain: Trevena's Oliceridine. The world of medicine is constantly evolving, and one company at the forefront of this evolution is Trevena, Inc. (NASDAQ: $TRVN). A biopharmaceutical company with a focus on developing innovative therapies, Trevena recently made headlines with the publication of their research in the PLOS ONE journal. The study, titled "Efficacy, safety, and side effects of oliceridine in acu...
Stocksgoup : 什麼消息?
Greg Sarantopoulos樓主 : 股票推特有人發布的一些消息。
Greg Sarantopoulos樓主 : 大約 30 分鐘前在斯托克推特中查看